MEDRx USA
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, MEDRx USA sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
MEDRx USA: 5 sponsored US clinical trials, none currently recruiting.
MEDRx USA sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 5 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bursitis, with 1 trials.
Upper-quartile sponsor footprint
MEDRx USA sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness
NCT02695381
Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain
NCT01968005
Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
NCT01506154
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains
NCT01198834
MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder
NCT01161615
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 5 |
Therapeutic Areas
How the MEDRx USA archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 5 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Bursitis (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
MEDRx USA: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
MEDRx USA sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this MEDRx USA page
5 registered trials is a research-attention snapshot, not an endorsement of MEDRx USA or any single study.
- None of MEDRx USA's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Bursitis is the condition MEDRx USA studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bursitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. MEDRx USA pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.